June 28, 2022 at 7:27 pm
Kezar Life Sciences (KZR) Shoots Up 43% On Promising Study Data
Kezar Life Sciences (KZR) soared 43% today as it has announced promising top-line data from their phase II study, called MISSION, evaluating its lead pipeline… [Read More]